Partnering to Achieve Epidemic Control in Cameroon

Date: 08/13/2015 Description: Cameroon PEPFAR Logo © PEPFAR

Get Acrobat Reader PDF Version

The United States is proud to support Cameroon’s leadership in the global HIV/AIDS response. PEPFAR provides service delivery and technical assistance in Cameroon to maximize the quality, coverage, and impact of the national HIV/AIDS response.

Working together with the Government of Cameroon, PEPFAR is aligning investments to scale up evidence-based interventions in the geographic areas and populations with the highest burden of HIV/AIDS–in line with PEPFAR 3.0. Cameroon is participating in the Accelerating Children’s HIV/AIDS Treatment (ACT) Initiative, a two-year effort to enable 300,000 more children living with HIV/AIDS to receive life-saving antiretroviral treatment (ART) across priority countries in sub-Saharan Africa. Specific priorities include the following:

  • Preventing mother-to-child transmission (PMTCT) of HIV
  • Scaling-up access to HIV prevention, care, and treatment among those most in need, particularly key and priority populations
  • Supporting health systems strengthening with a focus on improving health information systems, human resources for health, laboratory and blood safety systems, and supply chain management
  • Strengthening the continuum of care and treatment and ensuring linkages in the delivery of HIV prevention, care, and treatment across all levels of care


HIV/AIDS in Cameroon1

Number of people living with HIV (all ages), 2015

620,000

Deaths due to AIDS (all ages), 2015

33,000

Number of orphans due to AIDS (0-17), 2015   

310,000

Estimated antiretroviral treatment coverage (adults ages 15+), 2015

28%

Estimated percentage of pregnant women living with HIV who receive antiretroviral medications for PMTCT, 2015

82%

 

Saving Lives

In 2016, PEPFAR supported the following achievements in Cameroon:

  • Life-saving antiretroviral treatment for 142,455 people
  • Testing and counseling for 800,229 people
  • Care and support for 12,479 orphans and vulnerable children affected by HIV/AIDS
  • Antiretroviral medications for 11,811 pregnant women living with HIV to reduce mother-to-child transmission

Get the most up-to-date data on program results, expenditures, and planned funding at Data.pepfar.net.

PEPFAR Planned Funding in Cameroon2

FY 2016: $35 million
 
For complete fiscal year trends, please see the PEPFAR Dashboards.

1. UNAIDS. (2015). Cameroon: 2015 Country factsheets. Retrieved from http://aidsinfo.unaids.org/

2. Data reflect information available on the PEPFAR Dashboards and PEPFAR.gov, which represents planned new bilateral funding initially approved in the PEPFAR Country Operational Plans/Regional Operational Plans (COPs/ROPs) each fiscal year. As additional funding may be approved and made available after the initial COPs/ROPs submission, or to PEPFAR-supported countries that are not required to submit an annual COP/ROP, data on the Dashboards may not represent the final PEPFAR programmatic funding level in countries each fiscal year.


U.S. Government interagency website managed by the Office of U.S. Global AIDS Coordinator
and the Bureau of Public Affairs, U.S. State Department.
USA.gov | External Link Policy | Copyright Information | Privacy Policy | FOIA | Accessibility Statement | About State